select semaglutide trial and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the Long-term kidney outcomes of semaglutide

GLP-1 receptor agonists mimic the incretin hormone GLP-1, which stimulates insulin secretion, suppresses glucagon, slows gastric emptying, and promotes satiety

When monitoring your response to treatment, factors like how your clothes fit, your energy levels throughout the day, metabolic health markers, your food choices, and overall sense of well-being often provide more meaningful feedback than the number on the scale

Medical perspective Probiotics work best when a healthcare professional sees a need (not everyone will benefit from a probiotic and they can be harmful for some) and are taken alongside healthful lifestyle changes

For those using BPC-157 to address gastrointestinal issues, this is often when digestive symptoms begin to stabilize more consistently

Bevacizumab reduces PD-L1 Not PD-1 inhibitor-associated pneumonitis in non-small cell lung cancer patients